Skip to main content

and
  1. Article

    Open Access

    Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial

    The aim of this study was to assess the efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes inadequately controlled with metformin treatment.

    Linong Ji, Rikke M. Agesen, Stephen C. Bain, Fangming Fu, Sanaz Gabery in Diabetologia (2024)